Dilaudid and Postoperative wound complication - a phase IV clinical study of FDA data

Summary:

Postoperative wound complication is reported as a side effect among people who take Dilaudid (hydromorphone hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Levaquin, and have Osteoporosis.

The phase IV clinical study analyzes which people have Postoperative wound complication when taking Dilaudid. It is created by eHealthMe based on reports of 95,518 people who have side effects when taking Dilaudid from the FDA, and is updated regularly.

What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.

What is Postoperative wound complication?

Postoperative wound complication is found to be associated with 276 drugs and 315 conditions by eHealthMe. Check the latest studies of Postoperative wound complication.

On Jul, 14, 2026

95,518 people reported to have side effects when taking Dilaudid.
Among them, 20 people (0.02%) have Postoperative wound complication.

Could Dilaudid cause Postoperative wound complication?

Among these 20 people:

How long have people been on Dilaudid when they have Postoperative wound complication? *

What is the gender of people who have Postoperative wound complication when taking Dilaudid? *

female: 20 %
male: 80 %

What is the age of people who have Postoperative wound complication when taking Dilaudid? *

What are other drugs people take besides Dilaudid? *

What are other side effects people have besides Postoperative wound complication? *

Wound Dehiscence (a surgical incision reopens either internally or externally): 12 people, 60.00%
Joint Pain: 12 people, 60.00%
Pain In Extremity: 9 people, 45.00%
Pulmonary Embolism (blockage of the main artery of the lung): 9 people, 45.00%
Impaired Healing: 9 people, 45.00%
Hypoaesthesia (reduced sense of touch or sensation): 8 people, 40.00%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 8 people, 40.00%
Musculoskeletal Discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves): 8 people, 40.00%
Lymphadenopathy Mediastinal (an enlargement of the lymph nodes in the part of the chest that separates the lungs): 8 people, 40.00%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 8 people, 40.00%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 8 people, 40.00%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 20.00%
Diabetes: 4 people, 20.00%
High Blood Pressure: 3 people, 15.00%
Dyspnea (difficult or laboured breathing): 3 people, 15.00%
Thrombosis (formation of a blood clot inside a blood vessel): 3 people, 15.00%
Oropharyngeal Pain: 3 people, 15.00%
High Density Lipoprotein Decreased: 3 people, 15.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 15.00%
Bone Density Decreased: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Dilaudid and have Postoperative wound complication?

- Check whether Postoperative wound complication is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dilaudid:

Dilaudid (96,466 reports)

Browse all side effects of Dilaudid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Postoperative wound complication:

Postoperative wound complication (276 drugs)

Browse all the conditions that are associated with Postoperative wound complication:

Postoperative wound complication (315 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydromorphone hydrochloride (the active ingredients of Dilaudid) and Dilaudid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.